Details
Stereochemistry | RACEMIC |
Molecular Formula | C21H32O2 |
Molecular Weight | 316.4776 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC[C@@](O)(CC)[C@@]1(CC)CC[C@]3([H])[C@@]4([H])CCC(=O)C=C4CC[C@@]23[H]
InChI
InChIKey=FTBJKONNNSKOLX-XUDSTZEESA-N
InChI=1S/C21H32O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h13,16-19,23H,3-12H2,1-2H3/t16-,17+,18+,19-,20-,21-/m0/s1
Molecular Formula | C21H32O2 |
Molecular Weight | 316.4776 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Norbolethone is a 19-nor anabolic steroid first synthesized in 1966. During the 1960s it was administered to humans in efficacy studies concerned with short stature and underweight conditions. It has never been reported by doping control laboratories prior to 2001. Norbolethone matches the description for what is described as a "designer steroid. " In fact, Norbolethone was given in clinical trials over 30 years ago and never given the green light. No supply was ever manufactured, and no test was ever developed to detect this substance, yet ironically, it was suspected of being used in the 2000 Olympics based on blood and urine assays done by the IOC. Norbolethone was used in the treatment of idiopathic underweight, prevention of indomethacin-induced intestinal ulcers.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:35:01 UTC 2023
by
admin
on
Fri Dec 15 17:35:01 UTC 2023
|
Record UNII |
U3BZU2241A
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Official Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-Norbolethone
Created by
admin on Fri Dec 15 17:35:01 UTC 2023 , Edited by admin on Fri Dec 15 17:35:01 UTC 2023
|
||
|
NCI_THESAURUS |
C2360
Created by
admin on Fri Dec 15 17:35:01 UTC 2023 , Edited by admin on Fri Dec 15 17:35:01 UTC 2023
|
||
|
DEA NO. |
4000
Created by
admin on Fri Dec 15 17:35:01 UTC 2023 , Edited by admin on Fri Dec 15 17:35:01 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
U3BZU2241A
Created by
admin on Fri Dec 15 17:35:01 UTC 2023 , Edited by admin on Fri Dec 15 17:35:01 UTC 2023
|
PRIMARY | |||
|
m8044
Created by
admin on Fri Dec 15 17:35:01 UTC 2023 , Edited by admin on Fri Dec 15 17:35:01 UTC 2023
|
PRIMARY | Merck Index | ||
|
DTXSID50154027
Created by
admin on Fri Dec 15 17:35:01 UTC 2023 , Edited by admin on Fri Dec 15 17:35:01 UTC 2023
|
PRIMARY | |||
|
1235-15-0
Created by
admin on Fri Dec 15 17:35:01 UTC 2023 , Edited by admin on Fri Dec 15 17:35:01 UTC 2023
|
PRIMARY | |||
|
C90642
Created by
admin on Fri Dec 15 17:35:01 UTC 2023 , Edited by admin on Fri Dec 15 17:35:01 UTC 2023
|
PRIMARY | |||
|
C103408
Created by
admin on Fri Dec 15 17:35:01 UTC 2023 , Edited by admin on Fri Dec 15 17:35:01 UTC 2023
|
PRIMARY | |||
|
100000083591
Created by
admin on Fri Dec 15 17:35:01 UTC 2023 , Edited by admin on Fri Dec 15 17:35:01 UTC 2023
|
PRIMARY | |||
|
1856
Created by
admin on Fri Dec 15 17:35:01 UTC 2023 , Edited by admin on Fri Dec 15 17:35:01 UTC 2023
|
PRIMARY | |||
|
NORBOLETONE
Created by
admin on Fri Dec 15 17:35:01 UTC 2023 , Edited by admin on Fri Dec 15 17:35:01 UTC 2023
|
PRIMARY | |||
|
66255
Created by
admin on Fri Dec 15 17:35:01 UTC 2023 , Edited by admin on Fri Dec 15 17:35:01 UTC 2023
|
PRIMARY | |||
|
SUB09354MIG
Created by
admin on Fri Dec 15 17:35:01 UTC 2023 , Edited by admin on Fri Dec 15 17:35:01 UTC 2023
|
PRIMARY | |||
|
CHEMBL2105134
Created by
admin on Fri Dec 15 17:35:01 UTC 2023 , Edited by admin on Fri Dec 15 17:35:01 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ENANTIOMER -> RACEMATE |
|
||
|
ENANTIOMER -> RACEMATE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |